SCHEDULE 13G/A: Nomura Holdings Discloses 3.4% Stake in Cresco Labs Inc.
Beneficial Ownership Report (Schedule 13G Amendment)
Nomura Holdings Inc. and its subsidiary, Nomura Global Financial Products, Inc., have disclosed a beneficial ownership of 3.4% in Cresco Labs Inc., totaling 11,292,268 subordinate voting shares.
Summary
- Nomura Holdings Inc., a Japanese financial holding company, and its wholly-owned subsidiary, Nomura Global Financial Products, Inc. (NGFP), have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Cresco Labs Inc.
- As of March 31, 2025, the reporting persons collectively beneficially own 11,292,268 Subordinate Voting Shares of Cresco Labs Inc.
- This ownership represents 3.4% of Cresco Labs Inc.'s outstanding Subordinate Voting Shares.
- The percentage is calculated based on 331,490,358 Subordinate Voting Shares issued and outstanding as of December 31, 2024, as reported in Cresco Labs Inc.'s annual report on Form 40-F filed on March 14, 2025.
- The shares are held by NGFP, and Nomura Holdings Inc. is deemed to beneficially own them due to its control over NGFP.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of Cresco Labs Inc.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing disclosing beneficial ownership and does not convey positive or negative sentiment regarding the issuer's performance or outlook.
Risks
- The filing explicitly states that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating risks of hostile takeover attempts from this specific holding.
Future Outlook
The document is a beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding Cresco Labs Inc.'s future performance or strategic outlook.
Industry Context
This filing indicates a significant institutional investment by a major global financial institution, Nomura Holdings, in Cresco Labs Inc., a company operating in the cannabis industry. Such disclosures can signal growing institutional interest or confidence in the sector or specific companies within it.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holding by Nomura Holdings may be viewed positively, indicating institutional confidence or interest in Cresco Labs Inc.'s stock.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date as of which Cresco Labs Inc. reported 331,490,358 Subordinate Voting Shares issued and outstanding in its Form 40-F. |
| 2025-03-14 | Date Cresco Labs Inc. filed its annual report on Form 40-F for the fiscal year ended December 31, 2024. |
| 2025-03-31 | Date of event which requires the filing of this Schedule 13G statement. |
| 2025-05-15 | Date the Schedule 13G Amendment No. 2 was signed and filed. |
Keywords
Cresco Labs Inc., Nomura Holdings Inc., Nomura Global Financial Products Inc., Schedule 13G, Beneficial Ownership, Subordinate Voting Shares, SEC Filing, Institutional Ownership, Cannabis Industry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.